Less Money, Less Problems: Real-World Cost-Effectiveness of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention

[1]  T. Park,et al.  TCT-284 Long-Term Cost-Effectiveness of Fractional Flow Reserve in Stable and Unstable Angina Patients , 2022, Journal of the American College of Cardiology.

[2]  Theresa M. Beckie,et al.  2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Circulation.

[3]  M. Hlatky,et al.  Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease. , 2020, Journal of the American College of Cardiology.

[4]  T. Akasaka,et al.  Treatment strategy modification and its implication on the medical cost of fractional flow reserve-guided percutaneous coronary intervention in Japan. , 2019, Journal of cardiology.

[5]  P. Jüni,et al.  Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve , 2018, The New England journal of medicine.

[6]  J. Davies,et al.  The Evolving Future of Instantaneous Wave-Free Ratio and Fractional Flow Reserve. , 2017, Journal of the American College of Cardiology.

[7]  Uwe Siebert,et al.  Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease , 2010, Circulation.

[8]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. , 2010, Journal of the American College of Cardiology.

[9]  William Wijns,et al.  Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial , 2001, Circulation.